Three stories in MobiHealthNews were all so interesting we couldn't decide on just one.
Apps as therapy adjuncts are in the news again with an app from the Fred Hutchinson Cancer Research Center being used in a $3.1 million study by the center. This group has credibility as they have already run one clinical study that showed an increase of 5% in smoking cessation (13% compared to 8%) using their app, SmartQuit.
This study showed modest (2.9 points for self-management and 10.2 points for self-efficacy) improvements in the population of veterans who used PatientsLikeMe in an unstructured way.
“More than one-fourth of completers said that they had met a new person with epilepsy on the website, and 10 percent considered this new person to be a friend,” the researchers wrote. “Nearly half agreed or strongly agreed that PLM gave them more or better control over their condition and helped them understand their seizures.”
Google X (the health startup) is building a clinical-grade wearable for cardiac and activity tracking.
“In brief, we’ll be starting to use it in clinical studies to see if/how a continuous stream of medical-grade measurements of biological signals (e.g. pulse, skin temp, activity levels) could be useful to physicians and researchers as they try to understand and intervene earlier in disease,” a Google spokesperson told MobiHealthNews in an email. “This could give them insights that are currently only available sporadically – e.g. via a diagnostic test, or when a patient is being observed in a clinical setting.”